>
Organization
SAES Getters SpA
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on SAES Getters SpA

... the run-in period for these seven patients was 15.2. Serious adverse events (SAEs) were reported in four patients. Previously reported SAEs included: a patient with ...
... active doses following repeated administrations in the trial. There have been 21 SAEs reported, 11 of which were reported to be not related or unlikely ...
... pneumonia (2%), urinary tract infection to 18% of people receiving chemotherapy alone. SAEs occurring in 1% or more of people SAEs were reported in 23% ...
... cut-off date, there were no discontinuations from study treatment. Serious adverse events (SAEs) were reported for one patient (33 percent) receiving placebo and five patients ...
... show meaningful improvements in neuromuscular and respiratory function, with no new treatment-related SAEs reported since the last scientific update in May 2018. "The encouraging safety ...
... cut-off date, there were no discontinuations from study treatment. Serious adverse events (SAEs) were reported for one patient (33 percent) receiving placebo and five patients ...
... "Notes") in a private offering. The Notes are convertible into shares of SAE's common stock at an initial conversion price of $5.75 per share, subject ...
... of a 20-to-1 reverse split of its issued and outstanding common stock. SAE's common stock will begin trading on a split-adjusted basis when the market ...
... of a 20-to-1 reverse split of its issued and outstanding common stock. SAE's common stock will begin trading on a split-adjusted basis when the market ...
... Innovate trial results reaffirm Phase 3 protocol design No serious adverse events (SAEs) reported during the Innovate trial Phase 3 pivotal trials for molluscum contagiosum ...
Subscribe now for full coverage on SAES Getters SpA
Start My Free Trial